Incyte
INCY
#1062
Rank
C$32.24 B
Marketcap
C$161.42
Share price
5.78%
Change (1 day)
73.25%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$2.43 Billion

According to Incyte's latest financial reports the company's total liabilities are C$2.43 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$2.45 B-14.42%
2024-12-31C$2.86 B35.67%
2023-12-31C$2.11 B5.81%
2022-12-31C$1.99 B34.62%
2021-12-31C$1.48 B22.44%
2020-12-31C$1.21 B11.92%
2019-12-31C$1.08 B10.34%
2018-12-31C$0.98 B16.06%
2017-12-31C$0.84 B-48.43%
2016-12-31C$1.63 B41.22%
2015-12-31C$1.16 B13.84%
2014-12-31C$1.01 B16.36%
2013-12-31C$0.87 B74.26%
2012-12-31C$0.50 B-11.15%
2011-12-31C$0.56 B-2.14%
2010-12-31C$0.57 B-32.58%
2009-12-31C$0.85 B55.6%
2008-12-31C$0.55 B26.9%
2007-12-31C$0.43 B-14.96%
2006-12-31C$0.51 B11.44%
2005-12-31C$0.45 B-12.99%
2004-12-31C$0.52 B80.24%
2003-12-31C$0.29 B-25.93%
2002-12-31C$0.39 B-6.7%
2001-12-31C$0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
C$112.96 B 4,538.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$166.33 B 6,729.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$121.15 B 4,874.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$118.22 B 4,754.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.75 B-68.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C$0.48 B-79.92%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C$0.19 B-91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C$0.10 B-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.50 B-79.26%๐Ÿ‡บ๐Ÿ‡ธ USA